Delivery Order SPE2DB22D1106-SPE2DB24FFFW6
Award Date
8/9/24
Potential Completion Date
8/12/24
Potential Value
$6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of 4566102755 - Methylergonovine 0.2 mg/ml vials. The $1,662.94 firm fixed-price delivery order contract does not have a set-aside designation and has an ultimate completion date of October 16, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous Indefinite Delivery Contracts (IDCs) by the DLA and other...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $2,991.60 with a firm fixed price for the supply of 4563358199 - Methylergonovine 0.2 mg/mL vials. The contract has an ultimate completion date of January 19, 2024 and was awarded on January 18, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $1,007.70, was issued by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a Delivery Order contract with a Firm Fixed Price pricing type, and an ultimate completion date of February 19, 2025. The contract covers the procurement of 4567304287 units of Methylergonovine 0.2 mg/ml, a medication used to treat certain postpartum conditions. AmerisourceBergen holds a larger...
This federal contract award is between the Defense Logistics Agency (DLA) and Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,358.52, is for the delivery of methylergonovine 0.2 mg tablets to support military and government healthcare needs. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $2,873.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4560862324 - Methylergonovine 0.2 mg/ml vials, with a performance period ending on May 9, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The contract, valued at $1,304.87, is a firm fixed-price delivery order for the supply of 4565331970 - Methylergonovine 0.2 mg/ml vial. The contract has an ultimate completion date of August 5, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies,...
This federal contract award, valued at $1,859.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567118669 - Methylergonovine 0.2 mg/ml vial. This is a Firm Fixed Price Delivery Order contract with a completion date of February 3, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
The federal contract award is for the delivery of the pharmaceutical product Methylergonovine 0.2 mg/ml, valued at $2,874.65. The contract was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566416810 - Methylergonovine 0.2 mg/ml vials, with a ceiling value of $2,881.54 and a period of performance through November 14, 2024. The contract is a firm-fixed-price delivery order and was not designated as a set-aside. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,567,421,593 units of the pharmaceutical product Methylergonovine 0.2 mg Tablet. The $1,087.01 firm fixed-price contract has an ultimate completion date of March 3, 2025. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...